Europe Gene Synthesis (Research Use) Market To Reach $998.9 Million By 2030

Europe Gene Synthesis (Research Use) Market Growth & Trends

The Europe gene synthesis (research use) market size is expected to reach USD 998.9 million by 2030, growing at 15.8% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is mainly driven by various factors including favorable government policies and the development of enzymatic DNA synthetic process. Moreover, decreasing prices of DNA sequencing and synthesis support the market growth.

Gene synthesis is utilized in vaccine development to respond quickly against emerging infections. In addition, gene synthesis has an important role in developing viral vectors used as a delivery system in vaccine development. Viral vectors can deliver antigen genes into host cells, stimulating the immune system against pathogens. Thus, the significance of gene synthesis in vaccine development is projected to drive market growth during the forecast period.

The market has grown substantially over the last few years, owing to the decreasing prices of DNA synthesis and sequencing due to technological advances in human genome sequencing. Moreover, gene synthesis has unique capabilities to make physical copies of genes accurately, easily, and efficiently. The cost of gene synthesis per base pair has decreased drastically from about USD 10 to USD 0.10 over the past decade.

Furthermore, the favorable government policies regarding synthetic biology and several strategic initiatives undertaken by key players drive market growth. For instance, the UK Research Council established The Synthetic Biology for Growth program. The program was focused on research and investment in synthetic biology. The original duration of the program was from 2014 to 2020; however, due to the market's attractiveness, the program investments were extended till 2022.

Major players operating in the market are developing advanced technologies, launching innovative solutions, and partnering with others to gain a competitive advantage. For instance, in May 2023, Twist Bioscience announced the launch of a portfolio of RNA sequencing tools to accelerate biomarker discovery and precision medicine research. Such efforts by key players and the government are expected to fuel the market demand in the coming years.

 Request a free sample copy or view report summary: Europe Gene Synthesis (Research Use) Market Report

Europe Gene Synthesis (Research Use) Market Report Highlights

• By method, the solid phase synthesis segment accounted for the largest share in 2022. The segment is witnessing growth due to growing demand from various sectors, including pharmaceuticals, drug development, agriculture, and research

• By services, the antibody DNA synthesis segment accounted for the largest share in 2022. The dominance of the segment is attributable to the advancements in the field of recombinant antibody technology

• By application, the gene & cell therapy development segment dominated the market in 2022 and is expected to showcase the fastest CAGR over the forecast period. This growth mainly results from the rising use of gene synthesis methods for cloning synthetic therapeutic genes

• By the research phase, the clinical phase held the largest revenue share in 2022, and it is expected to witness the fastest CAGR over the forecast period. The rising number of clinical trials primarily drives this growth

• By end-use, the academic & government research institutions segment accounted for the largest share in 2022. The partnerships and strategic alliances between various companies and research institutes have also helped boost segment growth.

• France held the largest revenue share in 2022 in Europe, mainly due to the efforts of market participants to maintain their position and increase investment in industry in the country

• The Netherlands is expected to grow at the highest CAGR from 2023 to 2030. This is due to the presence of biotechnology companies and favorable government policies in the country

Europe Gene Synthesis (Research Use) Market Segmentation

Grand view research has segmented the Europe gene synthesis market based on method, service, application, research phase, end-use, region:

Europe Gene Synthesis (Research Use) Method Outlook (Revenue, USD Million, 2018 - 2030)

• Solid-phase Synthesis

• Chip-based Synthesis

• PCR-based Enzyme Synthesis

Europe Gene Synthesis (Research Use) Service Outlook (Revenue, USD Million, 2018 - 2030)

• Antibody DNA Synthesis

• Viral DNA Synthesis

• Others

Europe Gene Synthesis (Research Use) Application Outlook (Revenue, USD Million, 2018 - 2030)

• Gene & Cell Therapy Development

• Vaccine Development

• Others

Europe Gene Synthesis (Research Use) Research Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Pre-clinical

• Clinical

Europe Gene Synthesis (Research Use) End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology and Pharmaceutical Companies

• Academic and Government Research Institutes

• Contract Research Organizations

Europe Gene Synthesis (Research Use) Regional Outlook (Revenue, USD Million, 2018 - 2030)

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Netherland

  • Switzerland

List of key players in the Europe Gene Synthesis (Research Use) Market

• GenScript

• Azenta, Inc. (GENEWIZ)

• Boster Biological Technology

• Twist Bioscience

• ProteoGenix, Inc

• Biomatik

• ProMab Biotechnologies, Inc.

• Thermo Fisher Scientific, Inc.

• Integrated DNA Technologies, Inc. (Danaher)

• OriGene Technologies, Inc.